Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)

SHA:600381 Revenue

Qinghai Spring Medicinal Resources Technology had revenue of 59.65M CNY in the quarter ending September 30, 2024, with 11.94% growth. This brings the company's revenue in the last twelve months to 251.20M, up 30.67% year-over-year. In the year 2023, Qinghai Spring Medicinal Resources Technology had annual revenue of 213.88M with 33.52% growth.

• Revenue (ttm): 251.20M
• Revenue Growth: +30.67%
• P/S Ratio: 7.43
• Revenue / Employee: 1.45M
• Employees: 173
• Market Cap: 1.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	213.88M	53.70M	33.52%
Dec 31, 2022	160.18M	32.41M	25.37%
Dec 31, 2021	127.76M	3.50M	2.81%
Dec 31, 2020	124.27M	-109.48M	-46.84%
Dec 31, 2019	233.75M	-99.27M	-29.81%